Targeting ADCC: A different approach to HER2 breast cancer in the immunotherapy era
The clinical outcome of patients with human epidermal growth factor receptor 2 (HER2) amplified breast carcinoma (BC) has improved with the development of anti-HER2 targeted therapies. However, patients can experience disease recurrence after curative intent and disease progression in the metastatic...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2021-12-01
|
| Edice: | Breast |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S0960977621004379 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|